Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin

[1]  J. Nishioka,et al.  Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. , 2005, International journal of molecular medicine.

[2]  X. Leverve,et al.  Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. , 2004, The Biochemical journal.

[3]  W. Holland,et al.  Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. , 2004, Biochemical pharmacology.

[4]  A. Fukamizu,et al.  Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.

[5]  D. White,et al.  Functional silencing of hepatic microsomal glucose‐6‐phosphatase gene expression in vivo by adenovirus‐mediated delivery of short hairpin RNA , 2004, FEBS letters.

[6]  T. Osborne,et al.  PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis* , 2003, Journal of Biological Chemistry.

[7]  Giovanni Galli,et al.  Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.

[8]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[9]  M. Omata,et al.  A novel mitochondrial Ca2+-dependent solute carrier in the liver identified by mRNA differential display. , 2003, The Journal of biological chemistry.

[10]  P. Khatri,et al.  Global functional profiling of gene expression ? ? This work was funded in part by a Sun Microsystem , 2003 .

[11]  Steven C. Lawlor,et al.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.

[12]  Atul Butte,et al.  The use and analysis of microarray data , 2002, Nature Reviews Drug Discovery.

[13]  T. Saeki,et al.  Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. , 2002, Biochemical and biophysical research communications.

[14]  M. Kakei,et al.  Effect of metformin on adipose tissue resistin expression in db/db mice. , 2002, Biochemical and biophysical research communications.

[15]  T. Takeya,et al.  Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator* , 2002, The Journal of Biological Chemistry.

[16]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[17]  Duccio Cavalieri,et al.  Pathway Processor: a tool for integrating whole-genome expression results into metabolic networks. , 2002, Genome research.

[18]  Olle Ljunqvist,et al.  Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.

[19]  G. Mithieux,et al.  Polyunsaturated Fatty Acyl Coenzyme A Suppress the Glucose-6-phosphatase Promoter Activity by Modulating the DNA Binding of Hepatocyte Nuclear Factor 4α* , 2002, The Journal of Biological Chemistry.

[20]  T. Golub,et al.  DNA microarrays in clinical oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[22]  J. Girard,et al.  Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes. , 2001, Biochemical pharmacology.

[23]  K. Petersen,et al.  Mechanism by which metformin reduces glucose production in type 2 diabetes. , 2000, Diabetes.

[24]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[25]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[26]  Joshua M. Stuart,et al.  MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .

[27]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[28]  S. Hilsenbeck,et al.  Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. , 1999, Journal of the National Cancer Institute.

[29]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Michael Ruogu Zhang,et al.  Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. , 1998, Molecular biology of the cell.

[31]  Carolyn B Levy,et al.  Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. , 1998, Diabetes.

[32]  G. Reaven,et al.  Results of a Placebo-Controlled Study of the Metabolic Effects of the Addition of Metformin to Sulfonylurea-Treated Patients: Evidence for a central role of adipose tissue , 1997, Diabetes Care.

[33]  R. DeFronzo,et al.  Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[34]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[35]  R. DeFronzo,et al.  Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. , 1995, The New England journal of medicine.

[36]  G Dailey,et al.  Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[37]  R. Gougeon,et al.  Effect of NIDDM on the Kinetics of Whole-Body Protein Metabolism , 1994, Diabetes.

[38]  Lawrence A Leiter,et al.  Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. , 1992, Endocrinology.

[39]  P. Khatri,et al.  Global functional profiling of gene expression. , 2003, Genomics.

[40]  T. Osborne,et al.  PGC-1alpha activates CYP7A1 and bile acid biosynthesis. , 2003, The Journal of biological chemistry.

[41]  A. Hoffman,et al.  PRECLINICAL EVALUATION OF PHARMACOKINETIC PHARMACOKINETIC PHARMACODYNAMIC RATIONALE FOR ORAL CR METFORMIN FORMULATION , 2001 .

[42]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.